Genomic diversity of enterotoxigenic strains of Bacteroides fragilis

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Pierce, Jessica V ^a   Bernstein, Harris D ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; FRAGILYSIN; ENTEROTOXIN;

ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTEROIDES FRAGILIS; CONTROLLED STUDY; GENE IDENTIFICATION; GENETIC VARIABILITY; NONHUMAN; PATHOGENICITY; PHENOTYPE; PHYLOGENY; SEQUENCE ANALYSIS; TRANSPOSON; BIOFILM; BIOSYNTHESIS; CLASSIFICATION; GENE ORDER; GENETIC VARIATION; GENETICS; GENOMICS; GROWTH, DEVELOPMENT AND AGING; HIGH THROUGHPUT SEQUENCING; MOLECULAR EVOLUTION; PROCEDURES;

BACTEROIDES FRAGILIS; BIOFILMS; ENTEROTOXINS; EVOLUTION, MOLECULAR; GENE ORDER; GENES, BACTERIAL; GENETIC VARIATION; GENOME, BACTERIAL; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; PHYLOGENY;

EID: 84977072563     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0158171     Document Type: Article

References (52)

1. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009; 9(5):313-23. doi: 10.1038/nri2515 PMID: 19343057; PubMed Central PMCID: PMCPMC4095778.
2. Xu J, Gordon JI. Honor thy symbionts. Proc Natl Acad Sci U S A. 2003; 100(18):10452-9. doi: 10.1073/pnas.1734063100 PMID: 12923294; PubMed Central PMCID: PMCPMC193582.
3. Wu S, Lim KC, Huang J, Saidi RF, Sears CL. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc Natl Acad Sci U S A. 1998; 95(25):14979-84. PMID: 9844001; PubMed Central PMCID: PMCPMC24561.
4. Moncrief JS, Obiso R, Barroso LA, Kling JJ, Wright RL, Van Tassell RL, et al. The enterotoxin of Bacteroides fragilis is a metalloprotease. Infect Immun. 1995; 63(1):175-81. PMID: 7806355; PubMed Central PMCID: PMCPMC172975.
5. Franco AA. The Bacteroides fragilis pathogenicity island is contained in a putative novel conjugative transposon. J Bacteriol. 2004; 186(18):6077-92. doi: 10.1128/JB.186.18.6077-6092.2004 PMID: 15342577; PubMed Central PMCID: PMCPMC515173.
6. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009; 15(9):1016-22. doi: 10.1038/nm.2015 PMID: 19701202; PubMed Central PMCID: PMCPMC3034219.
7. Boleij A, Hechenbleikner EM, Goodwin AC, Badani R, Stein EM, Lazarev MG, et al. The Bacteroides fragilis Toxin Gene Is Prevalent in the Colon Mucosa of Colorectal Cancer Patients. Clin Infect Dis. 2015; 60(2):208-15. doi: 10.1093/cid/ciu787 PMID: 25305284.
8. Garrett WS. Cancer and the microbiota. Science. 2015; 348(6230):80-6. doi: 10.1126/science.aaa4972 PMID: 25838377.
9. Goodwin AC, Destefano Shields CE, Wu S, Huso DL, Wu X, Murray-Stewart TR, et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci U S A. 2011; 108(37):15354-9. doi: 10.1073/pnas.1010203108 PMID: 21876161; PubMed Central PMCID: PMCPMC3174648.
10. Sears CL, Geis AL, Housseau F. Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. J Clin Invest. 2014; 124(10):4166-72. doi: 10.1172/JCI72334 PMID: 25105360; PubMed Central PMCID: PMCPMC4191034.
11. Moncrief JS, Duncan AJ, Wright RL, Barroso LA, Wilkins TD. Molecular characterization of the fragilysin pathogenicity islet of enterotoxigenic Bacteroides fragilis. Infect Immun. 1998; 66(4):1735-9. PMID: 9529104; PubMed Central PMCID: PMCPMC108111.
12. Franco AA, Cheng RK, Chung GT, Wu S, Oh HB, Sears CL. Molecular evolution of the pathogenicity island of enterotoxigenic Bacteroides fragilis strains. J Bacteriol. 1999; 181(21):6623-33. PMID: 10542162; PubMed Central PMCID: PMCPMC94125.
13. Nikitina AS, Kharlampieva DD, Babenko VV, Shirokov DA, Vakhitova MT, Manolov AI, et al. Complete Genome Sequence of an Enterotoxigenic Bacteroides fragilis Clinical Isolate. Genome Announc. 2015; 3(3). doi: 10.1128/genomeA.00450-15 PMID: 25953165; PubMed Central PMCID: PMCPMC4424316.
14. Cerdeño-Tárraga AM, Patrick S, Crossman LC, Blakely G, Abratt V, Lennard N, et al. Extensive DNA inversions in the B. fragilis genome control variable gene expression. Science. 2005; 307(5714):1463-5. doi: 10.1126/science.1107008 PMID: 15746427.
15. Koropatkin NM, Cameron EA, Martens EC. How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol. 2012; 10(5):323-35. doi: 10.1038/nrmicro2746 PMID: 22491358; PubMed Central PMCID: PMCPMC4005082.
16. Martens EC, Chiang HC, Gordon JI. Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe. 2008; 4(5):447-57. doi: 10.1016/j.chom.2008.09.007 PMID: 18996345; PubMed Central PMCID: PMCPMC2605320.
17. Lee SM, Donaldson GP, Mikulski Z, Boyajian S, Ley K, Mazmanian SK. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature. 2013; 501(7467):426-9. doi: 10.1038/nature12447 PMID: 23955152; PubMed Central PMCID: PMCPMC3893107.
18. Chatzidaki-Livanis M, Coyne MJ, Comstock LE. An antimicrobial protein of the gut symbiont Bacteroides fragilis with a MACPF domain of host immune proteins. Mol Microbiol. 2014; 94(6):1361-74. doi: 10.1111/mmi.12839 PMID: 25339613; PubMed Central PMCID: PMCPMC4262677.
19. Russell AB, Peterson SB, Mougous JD. Type VI secretion system effectors: poisons with a purpose. Nat Rev Microbiol. 2014; 12(2):137-48. doi: 10.1038/nrmicro3185 PMID: 24384601; PubMed Central PMCID: PMCPMC4256078.
20. Russell AB, Wexler AG, Harding BN, Whitney JC, Bohn AJ, Goo YA, et al. A type VI secretion-related pathway in Bacteroidetes mediates interbacterial antagonism. Cell Host Microbe. 2014; 16(2):227-36. doi: 10.1016/j.chom.2014.07.007 PMID: 25070807; PubMed Central PMCID: PMCPMC4136423.
21. Salomon D, Kinch LN, Trudgian DC, Guo X, Klimko JA, Grishin NV, et al. Marker for type VI secretion system effectors. Proc Natl Acad Sci U S A. 2014; 111(25):9271-6. doi: 10.1073/pnas.1406110111 PMID: 24927539; PubMed Central PMCID: PMCPMC4078801.
22. Wexler AG, Bao Y, Whitney JC, Bobay LM, Xavier JB, Schofield WB, et al. Human symbionts inject and neutralize antibacterial toxins to persist in the gut. Proc Natl Acad Sci U S A. 2016. doi: 10.1073/pnas.1525637113 PMID: 26957597.
23. Chatzidaki-Livanis M, Geva-Zatorsky N, Comstock LE. Bacteroides fragilis type VI secretion systems use novel effector and immunity proteins to antagonize human gut Bacteroidales species. Proc Natl Acad Sci U S A. 2016. doi: 10.1073/pnas.1522510113 PMID: 26951680.
24. Coyne MJ, Zitomersky NL, McGuire AM, Earl AM, Comstock LE. Evidence of extensive DNA transfer between bacteroidales species within the human gut. MBio. 2014; 5(3):e01305-14. doi: 10.1128/mBio.01305-14 PMID: 24939888; PubMed Central PMCID: PMCPMC4073490.
25. Pumbwe L, Skilbeck CA, Nakano V, Avila-Campos MJ, Piazza RM, Wexler HM. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. Microb Pathog. 2007; 43(2-3):78-87. doi: 10.1016/j.micpath.2007.04.002 PMID: 17524609.
26. TerAvest MA, He Z, Rosenbaum MA, Martens EC, Cotta MA, Gordon JI, et al. Regulated expression of polysaccharide utilization and capsular biosynthesis loci in biofilm and planktonic Bacteroides thetaiotaomicron during growth in chemostats. Biotechnol Bioeng. 2014; 111(1):165-73. doi: 10.1002/bit.24994 PMID: 23996813; PubMed Central PMCID: PMCPMC3954753.
27. Dejea CM, Wick EC, Hechenbleikner EM, White JR, Mark Welch JL, Rossetti BJ, et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci U S A. 2014; 111 (51):18321-6. doi: 10.1073/pnas.1406199111 PMID: 25489084; PubMed Central PMCID: PMCPMC4280621.
28. Myers LL, Shoop DS, Stackhouse LL, Newman FS, Flaherty RJ, Letson GW, et al. Isolation of enterotoxigenic Bacteroides fragilis from humans with diarrhea. J Clin Microbiol. 1987; 25(12):2330-3. PMID: 3429625; PubMed Central PMCID: PMCPMC269482.
29. Weikel CS, Grieco FD, Reuben J, Myers LL, Sack RB. Human colonic epithelial cells, HT29/C1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology. Infect Immun. 1992; 60(2):321-7. PMID: 1730463; PubMed Central PMCID: PMCPMC257631.
30. Goris J, Konstantinidis KT, Klappenbach JA, Coenye T, Vandamme P, Tiedje JM. DNA-DNA hybridization values and their relationship to whole-genome sequence similarities. Int J Syst Evol Microbiol. 2007; 57(Pt 1):81-91. doi: 10.1099/ijs.0.64483-0 PMID: 17220447.
31. Wang Y, Coleman-Derr D, Chen G, Gu YQ. OrthoVenn: a web server for genome wide comparison and annotation of orthologous clusters across multiple species. Nucleic Acids Res. 2015; 43(W1):W78-84. doi: 10.1093/nar/gkv487 PMID: 25964301; PubMed Central PMCID: PMCPMC4489293.
32. Castillo D, Espejo R, Middelboe M. Genomic structure of bacteriophage 6H and its distribution as prophage in Flavobacterium psychrophilum strains. FEMS Microbiol Lett. 2014; 351(1):51-8. doi: 10.1111/1574-6968.12342 PMID: 24267868.
33. Cheng LF, Chen HM, Zheng T, Fu GH, Shi SH, Wan CH, et al. Complete genomic sequence of the virulent bacteriophage RAP44 of Riemerella anatipestifer. Avian Dis. 2012; 56(2):321-7. PMID: 22856189.
34. Franco AA, Mundy LM, Trucksis M, Wu S, Kaper JB, Sears CL. Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene. Infect Immun. 1997; 65(3):1007-13. PMID: 9038310; PubMed Central PMCID: PMCPMC175082.
35. Mundy LM, Sears CL. Detection of toxin production by Bacteroides fragilis: assay development and screening of extraintestinal clinical isolates. Clin Infect Dis. 1996; 23(2):269-76. PMID: 8842262.
36. Avelar KE, Pinto LJ, Antunes LC, Lobo LA, Bastos MC, Domingues RM, et al. Production of bacteriocin by Bacteriodes fragilis and partial characterization. Lett Appl Microbiol. 1999; 29(4):264-8. PMID: 10583756.
37. Papastathopoulou A, Bezirtzoglou E, Legakis NJ. Bacterioides fragilis: production and sensitivity to bacteriocins. Anaerobe. 1997; 3(2-3):203-6. doi: 10.1006/anae.1997.0106 PMID: 16887591.
38. Murphy K, O'Sullivan O, Rea MC, Cotter PD, Ross RP, Hill C. Genome mining for radical SAM protein determinants reveals multiple sactibiotic-like gene clusters. PLoS One. 2011; 6(7):e20852. doi: 10.1371/journal.pone.0020852 PMID: 21760885; PubMed Central PMCID: PMCPMC3132745.
39. Macfarlane S, Macfarlane GT. Composition and metabolic activities of bacterial biofilms colonizing food residues in the human gut. Appl Environ Microbiol. 2006; 72(9):6204-11. doi: 10.1128/AEM.00754-06 PMID: 16957247; PubMed Central PMCID: PMCPMC1563644.
40. Donelli G, Vuotto C, Cardines R, Mastrantonio P. Biofilm-growing intestinal anaerobic bacteria. FEMS Immunol Med Microbiol. 2012; 65(2):318-25. doi: 10.1111/j.1574-695X.2012.00962.x PMID: 22444687.
41. Johnson CH, Dejea CM, Edler D, Hoang LT, Santidrian AF, Felding BH, et al. Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metab. 2015; 21(6):891-7. doi: 10.1016/j.cmet.2015.04.011 PMID: 25959674; PubMed Central PMCID: PMCPMC4456201.
42. Lee J, Sperandio V, Frantz DE, Longgood J, Camilli A, Phillips MA, et al. An alternative polyamine biosynthetic pathway is widespread in bacteria and essential for biofilm formation in Vibrio cholerae. J Biol Chem. 2009; 284(15):9899-907. doi: 10.1074/jbc.M900110200 PMID: 19196710; PubMed Central PMCID: PMCPMC2665113.
43. Xu J, Mahowald MA, Ley RE, Lozupone CA, Hamady M, Martens EC, et al. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol. 2007; 5(7):e156. doi: 10.1371/journal.pbio.0050156 PMID: 17579514; PubMed Central PMCID: PMCPMC1892571.
44. Goodman AL, McNulty NP, Zhao Y, Leip D, Mitra RD, Lozupone CA, et al. Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe. 2009; 6(3):279-89. doi: 10.1016/j.chom.2009.08.003 PMID: 19748469; PubMed Central PMCID: PMCPMC2895552.
45. Kelsic ED, Zhao J, Vetsigian K, Kishony R. Counteraction of antibiotic production and degradation stabilizes microbial communities. Nature. 2015; 521(7553):516-9. doi: 10.1038/nature14485 PMID: 25992546.
46. Palm NW, de Zoete MR, Cullen TW, Barry NA, Stefanowski J, Hao L, et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell. 2014; 158(5):1000-10. doi: 10.1016/j.cell.2014.08.006 PMID: 25171403; PubMed Central PMCID: PMCPMC4174347.
47. Darling AE, Mau B, Perna NT. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One. 2010; 5(6):e11147. doi: 10.1371/journal.pone.0011147 PMID: 20593022; PubMed Central PMCID: PMCPMC2892488.
48. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, et al. The RAST Server: rapid annotations using subsystems technology. BMC Genomics. 2008; 9:75. doi: 10.1186/1471-2164-9-75 PMID: 18261238; PubMed Central PMCID: PMCPMC2265698.
49. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012; 67(11):2640-4. doi: 10.1093/jac/dks261 PMID: 22782487; PubMed Central PMCID: PMCPMC3468078.
50. de Jong A, van Heel AJ, Kok J, Kuipers OP. BAGEL2: mining for bacteriocins in genomic data. Nucleic Acids Res. 2010; 38(Web Server issue):W647-51. doi: 10.1093/nar/gkq365 PMID: 20462861; PubMed Central PMCID: PMCPMC2896169.
51. Zhou Y, Liang Y, Lynch KH, Dennis JJ, Wishart DS. PHAST: a fast phage search tool. Nucleic Acids Res. 2011; 39(Web Server issue):W347-52. doi: 10.1093/nar/gkr485 PMID: 21672955; PubMed Central PMCID: PMCPMC3125810.
52. Fernandez B, Le Lay C, Jean J, Fliss I. Growth, acid production and bacteriocin production by probiotic candidates under simulated colonic conditions. J Appl Microbiol. 2013; 114(3):877-85. doi: 10.1111/jam.12081 PMID: 23167818.